Roche Holdings Ltd ADR (RHHBY)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
42.6300 -0.7500 (-1.73%) 03/26/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 42.6300 unch (unch) 16:02 ET
for Wed, Mar 26th, 2025
Results
download Want to compare other data? Select Fields| Symbol | RHHBY | NVO | NVS | ||
| Company | Roche Holdings Ltd ADR | Novo Nordisk A/S ADR | Novartis Ag ADR | ||
| Price Information | |||||
| Exchange | OTC US | NYSE | NYSE | ||
| Open | 42.7600 | 72.56 | 109.08 | ||
| High | 43.3400 | 72.86 | 110.20 | ||
| Low | 42.4400 | 71.60 | 108.65 | ||
| Last | 42.6300 | 71.73 | 110.14 | ||
| Change | -0.7500 | -1.87 | -0.24 | ||
| % Change | -1.73% | -2.54% | -0.22% | ||
| Volume | 2,135,600 | 7,613,800 | 1,904,100 | ||
| 20-Day Average Volume | 5,268,020 | 7,047,885 | 2,545,130 | ||
| Previous Close | 43.3800 | 73.60 | 110.38 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 42.9688 | 81.21 | 111.35 | ||
| 20-Day Raw Stochastic | 46.50% | 0.64% | 27.98% | ||
| 20-Day Relative Strength | 54.71% | 35.13% | 52.64% | ||
| Weighted Alpha | +33.71 | -50.36 | +11.69 | ||
| Today's Opinion | 72% Buy | 100% Sell | 40% Buy | ||
| Previous Opinion | 100% Buy | 100% Sell | 40% Buy | ||
| Last Month's Opinion | 72% Buy | 56% Sell | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.68% since 03/19/25 | -9.20% since 03/19/25 | -1.27% since 03/19/25 | ||
| Low | 42.4400 on 03/26/25 | 71.60 on 03/26/25 | 108.65 on 03/26/25 | ||
| High | 43.8700 on 03/21/25 | 79.56 on 03/20/25 | 113.38 on 03/20/25 | ||
| 1-Month | |||||
| %Chg | +1.40% since 02/26/25 | -19.90% since 02/26/25 | +1.96% since 02/26/25 | ||
| Low | 41.1700 on 02/28/25 | 71.60 on 03/26/25 | 107.51 on 02/27/25 | ||
| High | 44.3100 on 03/17/25 | 91.90 on 03/05/25 | 116.91 on 03/10/25 | ||
| 3-Month | |||||
| %Chg | +21.80% since 12/26/24 | -18.16% since 12/26/24 | +11.93% since 12/26/24 | ||
| Low | 34.8600 on 12/27/24 | 71.60 on 03/26/25 | 96.91 on 01/02/25 | ||
| High | 44.3100 on 03/17/25 | 93.80 on 02/25/25 | 116.91 on 03/10/25 | ||
| 6-Month | |||||
| %Chg | +6.15% since 09/26/24 | -42.29% since 09/26/24 | -4.73% since 09/26/24 | ||
| Low | 34.1030 on 12/19/24 | 71.60 on 03/26/25 | 96.06 on 12/20/24 | ||
| High | 44.3100 on 03/17/25 | 121.34 on 09/27/24 | 117.36 on 10/18/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 271,891,424 | 321,890,688 | 225,126,160 | ||
| Shares Outstanding, K | 6,377,936 | 4,487,532 | 2,044,000 | ||
| Annual Sales | 68,725,890,000 | 42,108,430,000 | 51,722,000,000 | ||
| Annual Net Income | 9,403,160,000 | 14,643,260,000 | 11,941,000,000 | ||
| Last Quarter Sales | N/A | 12,261,320,000 | 13,558,000,000 | ||
| Last Quarter Net Income | N/A | 4,026,620,000 | 2,818,000,000 | ||
| 60-Month Beta | 0.41 | 0.42 | 0.53 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.91 on 02/05/25 | 1.98 on 01/31/25 | ||
| Latest Earnings Date | 02/06/25 | 05/01/25 | 04/22/25 | ||
| Most Recent Dividend | 0.856 on 03/28/25 | 0.362 on 08/16/24 | 2.515 on 03/12/25 | ||
| Next Ex-Dividends Date | 03/28/25 | 03/31/25 | 03/12/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.37 | 14.13 | ||